Clenbuterol acivicin decrease tumor growth muscle mass rats total parenteral nutrition problems supplemental nutrition tumor-bearing organisms control tumor growth reduction cachexia problems rats methylcholanthrene-induced sarcomas total parenteral nutrition TPN days days tumor inoculation treatment group rats glutamine antimetabolite acivicin beta agonist clenbuterol tumor growth skeletal muscle mass protein content gut mass total plasma lipid levels energy expenditure cardiac mass TPN acivicin clenbuterol results tumor growth muscle wasting TPN tumor-bearing organisms cachectic depletion lean body tissue obligatory neoplastic disease 